Aktienanalyse zu Canopy Growth Corp (CGC)CGCCanopy Growth Corp

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Canopy Growth Corp is currently not a strong buy due to its low current price of $0.9995 and an RSI of 38.823, indicating it is nearing oversold territory but not yet a clear buy signal. The forward P/E ratio of 20.37 suggests high future earnings expectations, but the recent insider selling has increased by 187.19%, which raises concerns about confidence in the stock. The main risk is the negative sentiment from analysts and the ongoing losses, with a net income loss of -157.11 million CAD in the latest quarter.